The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Highlights
The global Peptide Screening Service market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
The major global companies of Peptide Screening Service include Pepscan, Orbit Discovery, Creative Biolabs, GenScript, Creative Peptides, Eurogentec, Bio-Synthesis, JPT Peptide Technologies and Antibody Design Labs, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
Considering the economic change due to COVID-19, Solid-Phase Screening, which accounted for % of the global market of Peptide Screening Service in 2021, is expected to reach US$ million by 2028, growing at a revised CAGR of % from 2022 to 2028.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Peptide Screening Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide Screening Service.
The Peptide Screening Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Peptide Screening Service market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peptide Screening Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Some of the prominent players reviewed in the research report include:
- Pepscan
- Orbit Discovery
- Creative Biolabs
- GenScript
- Creative Peptides
- Eurogentec
- Bio-Synthesis
- JPT Peptide Technologies
- Antibody Design Labs
- HLA Proteins
- Synbio Technologies
- Lugen SCI
- Quimigen
- IRBM
- BIOSTEM
Product Type Insights
Global markets are presented by Peptide Screening Service type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Peptide Screening Service are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Peptide Screening Service segment by Type
- Solid-Phase Screening
- Solution-Sorting Screening
- Cell-based Screening
- In Vivo Screening
- Ex Vivo Screening
Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Peptide Screening Service market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Peptide Screening Service market.
Peptide Screening Service Segment by Application
- Structural Biology
- Peptide Drug Development
- Vaccine Development
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina, Colombia)
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Peptide Screening Service market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
- This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peptide Screening Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
- This report will help stakeholders to understand the global industry status and trends of Peptide Screening Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
- This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
- This report stays updated with novel technology integration, features, and the latest developments in the market
- This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Peptide Screening Service industry.
- This report helps stakeholders to gain insights into which regions to target globally
- This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peptide Screening Service.
- This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peptide Screening Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide Screening Service Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Solid-Phase Screening
1.2.3 Solution-Sorting Screening
1.2.4 Cell-based Screening
1.2.5 In Vivo Screening
1.2.6 Ex Vivo Screening
1.3 Market by Application
1.3.1 Global Peptide Screening Service Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Structural Biology
1.3.3 Peptide Drug Development
1.3.4 Vaccine Development
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Peptide Screening Service Market Perspective (2017-2028)
2.2 Peptide Screening Service Growth Trends by Region
2.2.1 Peptide Screening Service Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Peptide Screening Service Historic Market Size by Region (2017-2022)
2.2.3 Peptide Screening Service Forecasted Market Size by Region (2023-2028)
2.3 Peptide Screening Service Market Dynamics
2.3.1 Peptide Screening Service Industry Trends
2.3.2 Peptide Screening Service Market Drivers
2.3.3 Peptide Screening Service Market Challenges
2.3.4 Peptide Screening Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peptide Screening Service Players by Revenue
3.1.1 Global Top Peptide Screening Service Players by Revenue (2017-2022)
3.1.2 Global Peptide Screening Service Revenue Market Share by Players (2017-2022)
3.2 Global Peptide Screening Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Peptide Screening Service Revenue
3.4 Global Peptide Screening Service Market Concentration Ratio
3.4.1 Global Peptide Screening Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide Screening Service Revenue in 2021
3.5 Peptide Screening Service Key Players Head office and Area Served
3.6 Key Players Peptide Screening Service Product Solution and Service
3.7 Date of Enter into Peptide Screening Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide Screening Service Breakdown Data by Type
4.1 Global Peptide Screening Service Historic Market Size by Type (2017-2022)
4.2 Global Peptide Screening Service Forecasted Market Size by Type (2023-2028)
5 Peptide Screening Service Breakdown Data by Application
5.1 Global Peptide Screening Service Historic Market Size by Application (2017-2022)
5.2 Global Peptide Screening Service Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Peptide Screening Service Market Size (2017-2028)
6.2 North America Peptide Screening Service Market Size by Country (2017-2022)
6.3 North America Peptide Screening Service Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Peptide Screening Service Market Size (2017-2028)
7.2 Europe Peptide Screening Service Market Size by Country (2017-2022)
7.3 Europe Peptide Screening Service Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peptide Screening Service Market Size (2017-2028)
8.2 Asia-Pacific Peptide Screening Service Market Size by Country (2017-2022)
8.3 Asia-Pacific Peptide Screening Service Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Peptide Screening Service Market Size (2017-2028)
9.2 Latin America Peptide Screening Service Market Size by Country (2017-2022)
9.3 Latin America Peptide Screening Service Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peptide Screening Service Market Size (2017-2028)
10.2 Middle East & Africa Peptide Screening Service Market Size by Country (2017-2022)
10.3 Middle East & Africa Peptide Screening Service Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Pepscan
11.1.1 Pepscan Company Detail
11.1.2 Pepscan Business Overview
11.1.3 Pepscan Peptide Screening Service Introduction
11.1.4 Pepscan Revenue in Peptide Screening Service Business (2017-2022)
11.1.5 Pepscan Recent Development
11.2 Orbit Discovery
11.2.1 Orbit Discovery Company Detail
11.2.2 Orbit Discovery Business Overview
11.2.3 Orbit Discovery Peptide Screening Service Introduction
11.2.4 Orbit Discovery Revenue in Peptide Screening Service Business (2017-2022)
11.2.5 Orbit Discovery Recent Development
11.3 Creative Biolabs
11.3.1 Creative Biolabs Company Detail
11.3.2 Creative Biolabs Business Overview
11.3.3 Creative Biolabs Peptide Screening Service Introduction
11.3.4 Creative Biolabs Revenue in Peptide Screening Service Business (2017-2022)
11.3.5 Creative Biolabs Recent Development
11.4 GenScript
11.4.1 GenScript Company Detail
11.4.2 GenScript Business Overview
11.4.3 GenScript Peptide Screening Service Introduction
11.4.4 GenScript Revenue in Peptide Screening Service Business (2017-2022)
11.4.5 GenScript Recent Development
11.5 Creative Peptides
11.5.1 Creative Peptides Company Detail
11.5.2 Creative Peptides Business Overview
11.5.3 Creative Peptides Peptide Screening Service Introduction
11.5.4 Creative Peptides Revenue in Peptide Screening Service Business (2017-2022)
11.5.5 Creative Peptides Recent Development
11.6 Eurogentec
11.6.1 Eurogentec Company Detail
11.6.2 Eurogentec Business Overview
11.6.3 Eurogentec Peptide Screening Service Introduction
11.6.4 Eurogentec Revenue in Peptide Screening Service Business (2017-2022)
11.6.5 Eurogentec Recent Development
11.7 Bio-Synthesis
11.7.1 Bio-Synthesis Company Detail
11.7.2 Bio-Synthesis Business Overview
11.7.3 Bio-Synthesis Peptide Screening Service Introduction
11.7.4 Bio-Synthesis Revenue in Peptide Screening Service Business (2017-2022)
11.7.5 Bio-Synthesis Recent Development
11.8 JPT Peptide Technologies
11.8.1 JPT Peptide Technologies Company Detail
11.8.2 JPT Peptide Technologies Business Overview
11.8.3 JPT Peptide Technologies Peptide Screening Service Introduction
11.8.4 JPT Peptide Technologies Revenue in Peptide Screening Service Business (2017-2022)
11.8.5 JPT Peptide Technologies Recent Development
11.9 Antibody Design Labs
11.9.1 Antibody Design Labs Company Detail
11.9.2 Antibody Design Labs Business Overview
11.9.3 Antibody Design Labs Peptide Screening Service Introduction
11.9.4 Antibody Design Labs Revenue in Peptide Screening Service Business (2017-2022)
11.9.5 Antibody Design Labs Recent Development
11.10 HLA Proteins
11.10.1 HLA Proteins Company Detail
11.10.2 HLA Proteins Business Overview
11.10.3 HLA Proteins Peptide Screening Service Introduction
11.10.4 HLA Proteins Revenue in Peptide Screening Service Business (2017-2022)
11.10.5 HLA Proteins Recent Development
11.11 Synbio Technologies
11.11.1 Synbio Technologies Company Detail
11.11.2 Synbio Technologies Business Overview
11.11.3 Synbio Technologies Peptide Screening Service Introduction
11.11.4 Synbio Technologies Revenue in Peptide Screening Service Business (2017-2022)
11.11.5 Synbio Technologies Recent Development
11.12 Lugen SCI
11.12.1 Lugen SCI Company Detail
11.12.2 Lugen SCI Business Overview
11.12.3 Lugen SCI Peptide Screening Service Introduction
11.12.4 Lugen SCI Revenue in Peptide Screening Service Business (2017-2022)
11.12.5 Lugen SCI Recent Development
11.13 Quimigen
11.13.1 Quimigen Company Detail
11.13.2 Quimigen Business Overview
11.13.3 Quimigen Peptide Screening Service Introduction
11.13.4 Quimigen Revenue in Peptide Screening Service Business (2017-2022)
11.13.5 Quimigen Recent Development
11.14 IRBM
11.14.1 IRBM Company Detail
11.14.2 IRBM Business Overview
11.14.3 IRBM Peptide Screening Service Introduction
11.14.4 IRBM Revenue in Peptide Screening Service Business (2017-2022)
11.14.5 IRBM Recent Development
11.15 BIOSTEM
11.15.1 BIOSTEM Company Detail
11.15.2 BIOSTEM Business Overview
11.15.3 BIOSTEM Peptide Screening Service Introduction
11.15.4 BIOSTEM Revenue in Peptide Screening Service Business (2017-2022)
11.15.5 BIOSTEM Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Peptide Screening Service Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Solid-Phase Screening
Table 3. Key Players of Solution-Sorting Screening
Table 4. Key Players of Cell-based Screening
Table 5. Key Players of In Vivo Screening
Table 6. Key Players of Ex Vivo Screening
Table 7. Global Peptide Screening Service Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Peptide Screening Service Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Peptide Screening Service Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Peptide Screening Service Market Share by Region (2017-2022)
Table 11. Global Peptide Screening Service Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Peptide Screening Service Market Share by Region (2023-2028)
Table 13. Peptide Screening Service Market Trends
Table 14. Peptide Screening Service Market Drivers
Table 15. Peptide Screening Service Market Challenges
Table 16. Peptide Screening Service Market Restraints
Table 17. Global Peptide Screening Service Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Peptide Screening Service Market Share by Players (2017-2022)
Table 19. Global Top Peptide Screening Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Screening Service as of 2021)
Table 20. Ranking of Global Top Peptide Screening Service Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Peptide Screening Service Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Peptide Screening Service Product Solution and Service
Table 24. Date of Enter into Peptide Screening Service Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Peptide Screening Service Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Peptide Screening Service Revenue Market Share by Type (2017-2022)
Table 28. Global Peptide Screening Service Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Peptide Screening Service Revenue Market Share by Type (2023-2028)
Table 30. Global Peptide Screening Service Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Peptide Screening Service Revenue Market Share by Application (2017-2022)
Table 32. Global Peptide Screening Service Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Peptide Screening Service Revenue Market Share by Application (2023-2028)
Table 34. North America Peptide Screening Service Market Size by Country (2017-2022) & (US$ Million)
Table 35. North America Peptide Screening Service Market Size by Country (2023-2028) & (US$ Million)
Table 36. Europe Peptide Screening Service Market Size by Country (2017-2022) & (US$ Million)
Table 37. Europe Peptide Screening Service Market Size by Country (2023-2028) & (US$ Million)
Table 38. Asia-Pacific Peptide Screening Service Market Size by Region (2017-2022) & (US$ Million)
Table 39. Asia-Pacific Peptide Screening Service Market Size by Region (2023-2028) & (US$ Million)
Table 40. Latin America Peptide Screening Service Market Size by Country (2017-2022) & (US$ Million)
Table 41. Latin America Peptide Screening Service Market Size by Country (2023-2028) & (US$ Million)
Table 42. Middle East & Africa Peptide Screening Service Market Size by Country (2017-2022) & (US$ Million)
Table 43. Middle East & Africa Peptide Screening Service Market Size by Country (2023-2028) & (US$ Million)
Table 44. Pepscan Company Detail
Table 45. Pepscan Business Overview
Table 46. Pepscan Peptide Screening Service Product
Table 47. Pepscan Revenue in Peptide Screening Service Business (2017-2022) & (US$ Million)
Table 48. Pepscan Recent Development
Table 49. Orbit Discovery Company Detail
Table 50. Orbit Discovery Business Overview
Table 51. Orbit Discovery Peptide Screening Service Product
Table 52. Orbit Discovery Revenue in Peptide Screening Service Business (2017-2022) & (US$ Million)
Table 53. Orbit Discovery Recent Development
Table 54. Creative Biolabs Company Detail
Table 55. Creative Biolabs Business Overview
Table 56. Creative Biolabs Peptide Screening Service Product
Table 57. Creative Biolabs Revenue in Peptide Screening Service Business (2017-2022) & (US$ Million)
Table 58. Creative Biolabs Recent Development
Table 59. GenScript Company Detail
Table 60. GenScript Business Overview
Table 61. GenScript Peptide Screening Service Product
Table 62. GenScript Revenue in Peptide Screening Service Business (2017-2022) & (US$ Million)
Table 63. GenScript Recent Development
Table 64. Creative Peptides Company Detail
Table 65. Creative Peptides Business Overview
Table 66. Creative Peptides Peptide Screening Service Product
Table 67. Creative Peptides Revenue in Peptide Screening Service Business (2017-2022) & (US$ Million)
Table 68. Creative Peptides Recent Development
Table 69. Eurogentec Company Detail
Table 70. Eurogentec Business Overview
Table 71. Eurogentec Peptide Screening Service Product
Table 72. Eurogentec Revenue in Peptide Screening Service Business (2017-2022) & (US$ Million)
Table 73. Eurogentec Recent Development
Table 74. Bio-Synthesis Company Detail
Table 75. Bio-Synthesis Business Overview
Table 76. Bio-Synthesis Peptide Screening Service Product
Table 77. Bio-Synthesis Revenue in Peptide Screening Service Business (2017-2022) & (US$ Million)
Table 78. Bio-Synthesis Recent Development
Table 79. JPT Peptide Technologies Company Detail
Table 80. JPT Peptide Technologies Business Overview
Table 81. JPT Peptide Technologies Peptide Screening Service Product
Table 82. JPT Peptide Technologies Revenue in Peptide Screening Service Business (2017-2022) & (US$ Million)
Table 83. JPT Peptide Technologies Recent Development
Table 84. Antibody Design Labs Company Detail
Table 85. Antibody Design Labs Business Overview
Table 86. Antibody Design Labs Peptide Screening Service Product
Table 87. Antibody Design Labs Revenue in Peptide Screening Service Business (2017-2022) & (US$ Million)
Table 88. Antibody Design Labs Recent Development
Table 89. HLA Proteins Company Detail
Table 90. HLA Proteins Business Overview
Table 91. HLA Proteins Peptide Screening Service Product
Table 92. HLA Proteins Revenue in Peptide Screening Service Business (2017-2022) & (US$ Million)
Table 93. HLA Proteins Recent Development
Table 94. Synbio Technologies Company Detail
Table 95. Synbio Technologies Business Overview
Table 96. Synbio Technologies Peptide Screening ServiceProduct
Table 97. Synbio Technologies Revenue in Peptide Screening Service Business (2017-2022) & (US$ Million)
Table 98. Synbio Technologies Recent Development
Table 99. Lugen SCI Company Detail
Table 100. Lugen SCI Business Overview
Table 101. Lugen SCI Peptide Screening ServiceProduct
Table 102. Lugen SCI Revenue in Peptide Screening Service Business (2017-2022) & (US$ Million)
Table 103. Lugen SCI Recent Development
Table 104. Quimigen Company Detail
Table 105. Quimigen Business Overview
Table 106. Quimigen Peptide Screening ServiceProduct
Table 107. Quimigen Revenue in Peptide Screening Service Business (2017-2022) & (US$ Million)
Table 108. Quimigen Recent Development
Table 109. IRBM Company Detail
Table 110. IRBM Business Overview
Table 111. IRBM Peptide Screening ServiceProduct
Table 112. IRBM Revenue in Peptide Screening Service Business (2017-2022) & (US$ Million)
Table 113. IRBM Recent Development
Table 114. BIOSTEM Company Detail
Table 115. BIOSTEM Business Overview
Table 116. BIOSTEM Peptide Screening ServiceProduct
Table 117. BIOSTEM Revenue in Peptide Screening Service Business (2017-2022) & (US$ Million)
Table 118. BIOSTEM Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peptide Screening Service Market Share by Type: 2021 VS 2028
Figure 2. Solid-Phase Screening Features
Figure 3. Solution-Sorting Screening Features
Figure 4. Cell-based Screening Features
Figure 5. In Vivo Screening Features
Figure 6. Ex Vivo Screening Features
Figure 7. Global Peptide Screening Service Market Share by Application in 2021 & 2028
Figure 8. Structural Biology Case Studies
Figure 9. Peptide Drug Development Case Studies
Figure 10. Vaccine Development Case Studies
Figure 11. Peptide Screening Service Report Years Considered
Figure 12. Global Peptide Screening Service Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Peptide Screening Service Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Peptide Screening Service Market Share by Region: 2021 VS 2028
Figure 15. Global Peptide Screening Service Market Share by Players in 2021
Figure 16. Global Top Peptide Screening Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Screening Service as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Peptide Screening Service Revenue in 2021
Figure 18. North America Peptide Screening Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. North America Peptide Screening Service Market Share by Country (2017-2028)
Figure 20. United States Peptide Screening Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Peptide Screening Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Peptide Screening Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Peptide Screening Service Market Share by Country (2017-2028)
Figure 24. Germany Peptide Screening Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France Peptide Screening Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. Peptide Screening Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy Peptide Screening Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia Peptide Screening Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries Peptide Screening Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Peptide Screening Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Peptide Screening Service Market Share by Region (2017-2028)
Figure 32. China Peptide Screening Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Japan Peptide Screening Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. South Korea Peptide Screening Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Southeast Asia Peptide Screening Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. India Peptide Screening Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Australia Peptide Screening Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Peptide Screening Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Peptide Screening Service Market Share by Country (2017-2028)
Figure 40. Mexico Peptide Screening Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Brazil Peptide Screening Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Peptide Screening Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Peptide Screening Service Market Share by Country (2017-2028)
Figure 44. Turkey Peptide Screening Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Saudi Arabia Peptide Screening Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Pepscan Revenue Growth Rate in Peptide Screening Service Business (2017-2022)
Figure 47. Orbit Discovery Revenue Growth Rate in Peptide Screening Service Business (2017-2022)
Figure 48. Creative Biolabs Revenue Growth Rate in Peptide Screening Service Business (2017-2022)
Figure 49. GenScript Revenue Growth Rate in Peptide Screening Service Business (2017-2022)
Figure 50. Creative Peptides Revenue Growth Rate in Peptide Screening Service Business (2017-2022)
Figure 51. Eurogentec Revenue Growth Rate in Peptide Screening Service Business (2017-2022)
Figure 52. Bio-Synthesis Revenue Growth Rate in Peptide Screening Service Business (2017-2022)
Figure 53. JPT Peptide Technologies Revenue Growth Rate in Peptide Screening Service Business (2017-2022)
Figure 54. Antibody Design Labs Revenue Growth Rate in Peptide Screening Service Business (2017-2022)
Figure 55. HLA Proteins Revenue Growth Rate in Peptide Screening Service Business (2017-2022)
Figure 56. Synbio Technologies Revenue Growth Rate in Peptide Screening Service Business (2017-2022)
Figure 57. Lugen SCI Revenue Growth Rate in Peptide Screening Service Business (2017-2022)
Figure 58. Quimigen Revenue Growth Rate in Peptide Screening Service Business (2017-2022)
Figure 59. IRBM Revenue Growth Rate in Peptide Screening Service Business (2017-2022)
Figure 60. BIOSTEM Revenue Growth Rate in Peptide Screening Service Business (2017-2022)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
